GeoVax Presenting at Upcoming Scientific Conferences
November 07, 2018 09:00 ET
|
GeoVax, Inc.
Plug & Play Platform Continues to be Recognized for Distinct Benefits ATLANTA, GA, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
New Study Suggests Zika Virus Eradication in the Americas May Become Impossible, Making the Need for a Vaccine Even More Critical
November 05, 2018 10:04 ET
|
GeoVax, Inc.
GeoVax Comments on New Study Conducted in Brazil ATLANTA, GA, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
GeoVax Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference
October 24, 2018 11:00 ET
|
GeoVax, Inc.
Booster Vaccination After ~7 Years Resulted in 600-fold Increase in Antibody Response ATLANTA, GA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax Announces Publication of HIV Vaccines Review
October 22, 2018 09:00 ET
|
GeoVax, Inc.
Comprehensive Review Published in the Peer-Reviewed Journal, Clinical Pharmacology and Therapeutics ATLANTA, GA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...
GeoVax Observes National Latinx AIDS Awareness Day
October 15, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Latinx AIDS...
GeoVax Observes National Gay Men’s HIV/AIDS Awareness Day
September 27, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Gay Men’s HIV/AIDS...
GeoVax Awarded $2.4 Million from U.S. Department of Defense to Advance Lassa Fever Vaccine
September 26, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines, announced today that the U.S....
GeoVax Comments on Age-Associated HIV Infection Trends in the U.S.
September 24, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today commented on recent age-associated HIV...
GeoVax Strengthens Scientific Staff and Expertise
August 29, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced the strengthening of its...
GeoVax Announces Appointment of David Dodd as Chairman, President and Chief Executive Officer
August 14, 2018 09:00 ET
|
GeoVax, Inc.
Current President & CEO Robert McNally to Retire Effective August 31 ATLANTA, GA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...